Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.831 CHF
−49.98 M CHF
311.26 M CHF
13.27 M
About POLYPEPTIDE N
Sector
Industry
CEO
Juan-José Gonzalez
Website
Headquarters
Baar
Founded
1996
ISIN
CH1110760852
FIGI
BBG0100P02W2
PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1996 and is headquartered in Zug, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8H0 is 27.195 CHF — it has decreased by −15.31% in the past 24 hours. Watch POLYPEPTIDE GROUP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange POLYPEPTIDE GROUP stocks are traded under the ticker 8H0.
We've gathered analysts' opinions on POLYPEPTIDE GROUP future price: according to them, 8H0 price has a max estimate of 44.67 CHF and a min estimate of 33.26 CHF. Watch 8H0 chart and read a more detailed POLYPEPTIDE GROUP stock forecast: see what analysts think of POLYPEPTIDE GROUP and suggest that you do with its stocks.
8H0 stock is 18.08% volatile and has beta coefficient of 1.58. Track POLYPEPTIDE GROUP stock price on the chart and check out the list of the most volatile stocks — is POLYPEPTIDE GROUP there?
Today POLYPEPTIDE GROUP has the market capitalization of 921.89 M, it has increased by 3.61% over the last week.
Yes, you can track POLYPEPTIDE GROUP financials in yearly and quarterly reports right on TradingView.
POLYPEPTIDE GROUP is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
8H0 earnings for the last half-year are −0.34 CHF per share, whereas the estimation was −0.68 CHF, resulting in a 50.70% surprise. The estimated earnings for the next half-year are 0.06 CHF per share. See more details about POLYPEPTIDE GROUP earnings.
POLYPEPTIDE GROUP revenue for the last half-year amounts to 130.00 M CHF, despite the estimated figure of 129.15 M CHF. In the next half-year revenue is expected to reach 195.85 M CHF.
8H0 net income for the last half-year is −10.95 M CHF, while the previous report showed −16.45 M CHF of net income which accounts for 33.43% change. Track more POLYPEPTIDE GROUP financial stats to get the full picture.
As of Dec 12, 2024, the company has 1.27 K employees. See our rating of the largest employees — is POLYPEPTIDE GROUP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. POLYPEPTIDE GROUP EBITDA is 12.01 M CHF, and current EBITDA margin is −3.27%. See more stats in POLYPEPTIDE GROUP financial statements.
Like other stocks, 8H0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POLYPEPTIDE GROUP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So POLYPEPTIDE GROUP technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating POLYPEPTIDE GROUP stock shows the neutral signal. See more of POLYPEPTIDE GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.